Theras is celebrating its 15th anniversary and is focusing on diabetes, chronic pain and weight management

Theras, the Italian biomedical company founded in 2011 in Salsomaggiore Terme, is preparing to mark its first 15 years. To celebrate this anniversary, it is set to announce “Theras for Sport with Alice Degradi”. A project that combines sport with raising awareness of type 1 diabetes and chronic conditions. The initiative, which will kick off in Salsomaggiore with the Under-16 girls’ volleyball tournament on 13 June, aims to engage the younger generation through the language of sport, promoting awareness, inclusion and health through the involvement of Alice Degradi, a professional volleyball player with type 1 diabetes.

Fifteen years after its foundation, Theras continues to grow and is targeting consolidated revenues of over €290 million in 2026. The group, which operates in the medtech sector, recorded revenues of €131 million in 2024, thanks to its 2020–2030 development plan based on M&A activities, the expansion of therapeutic segments and gradual international expansion. The recent acquisition of Pic Solution is projected to drive Theras’ growth by approximately 87%. The consolidated figures for 2025 will be officially presented during the summer. Founded in 2011 in Salsomaggiore Terme with a team of three people, Theras has grown to now have over 300 employees, a portfolio of 150 technologies, 101 ongoing development projects and 27 patents, within one of Europe’s leading biomedical clusters – the Italia one – recognised for its concentration of expertise and innovation.

The 2030 development plan focused on three main areas: strengthening the company’s position in the diabetes, chronic pain and weight management segments; expanding the product portfolio; and diversifying sales channels and driving growth through targeted acquisitions. Alongside its expansion, the company embarked on a process of professionalising its management and consolidated an organisational structure capable of supporting this growth. A decisive step in the Group’s journey was marked by M&A transactions. First came the acquisition of a stake in Gelesis, an Italian manufacturer of a medical device for weight loss, with the aim of making innovation originating in Italy accessible to all. Then came the acquisition of PIC Solution, a historic Italian brand present in over 11,000 pharmacies, which strengthened the company’s positioning and opened direct access to the medical self-care market, diversifying channels and enabling entry into foreign markets. The expansion is focused in particular on Europe. people every day.

“Our journey stems from a clear vision: to put the patient at the centre and build an ecosystem of practical solutions around them,” says Federico Ferrari, CEO of the Group. “Today, Theras is a solid and growing organisation, but above all it is a collective project that brings together expertise, technology and a willingness to listen. It is a company where people feel a sense of belonging and participate actively, which is also why the fifteenth anniversary is particularly meaningful within the group. In the coming years, we want to further accelerate our growth, strengthen integration across different therapeutic areas, and make our solutions increasingly accessible and capable of generating a real impact on people’s lives.”